Analyze Portfolio
Nasdaq · Healthcare

BNB PLUS CORP. (BNBX)

As-reported financials and recent SEC filings for BNB PLUS CORP., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue
$2.1M
Net income
$-15.2M
Net margin
Diluted EPS
$-134.23
ROE
-780.8%
P/E (TTM)
Market cap
Debt / equity

Income statement (as reported)

LineFY2025FY2024FY2023FY2022FY2021
Revenue$2.1M$2.1M$13.4M$18.2M$9.0M
Gross profit$838,907$974,840$5.5M$5.1M$4.5M
Operating income$-16.0M$-13.7M$-11.0M$-14.0M$-13.3M
Net income$-15.2M$-7.0M$-9.9M$-8.3M$-14.3M
Diluted EPS$-134.23$-13.94$-19.25$-16.47$-36.67

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-07-02
View on EDGAR →
8-K/A2026-06-25
View on EDGAR →
SCHEDULE 13D/A2026-06-17
View on EDGAR →
SCHEDULE 13D2026-06-04
View on EDGAR →
8-K/A2026-06-03
View on EDGAR →
8-K2026-05-27
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Go deeper on BNBX

Search BNB PLUS CORP.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.